Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 14/20 | 1.00 |
| ▸ | FPR1 | P21462 | 2/20 | 0.85 |
| ▸ | PPIA | P62937 | 6/20 | 0.83 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.83 |
| ▸ | ABCC2 | Q92887 | 2/20 | 0.83 |
| ▸ | FKBP1B | P68106 | 2/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | NPC1 | O15118 | 1/20 | 0.83 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.83 |
| ▸ | GMNN | O75496 | 1/20 | 0.83 |
| ▸ | USP2 | O75604 | 1/20 | 0.83 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.83 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.83 |
| ▸ | LMNA | P02545 | 1/20 | 0.83 |
| ▸ | POLB | P06746 | 1/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 1/20 | 0.83 |
| ▸ | RARB | P10826 | 1/20 | 0.83 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.83 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20180085 | 1.00 | ABCB1 (1.00) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL21165779 | 1.00 | ABCB1 (1.00) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL14435531 | 1.00 | ABCB1 (1.00) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL22047168 | 1.00 | ABCB1 (1.00) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL20076121 | 0.97 | ABCB1 (0.94) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL21016042 | 0.96 | ABCB1 (0.92) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL23320225 | 0.96 | ABCB1 (0.92) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL22435569 | 0.96 | ABCB1 (0.91) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL22251734 | 0.95 | ABCB1 (0.91) | ABCB1FPR1PPIAABCC1ABCC2 | |
| SCHEMBL16063958 | 0.95 | ABCB1 (0.90) | ABCB1FPR1PPIAABCC1ABCC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025079025-A1 | IDES-RAPAMYCIN CONJUGATE IN AAV GENE THERAPY | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-04-17 | — | — | WO | disclosed |
| EP-3352796-B1 | DRUG FORMULATION BASED ON PARTICULATES COMPRISING POLYSACCHARIDE-VITAMIN CONJUGATE | U S TIANYOU CAPITAL CORP (US) | 2025-03-05 | — | — | EP | disclosed |
| US-20240426814-A1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-12-26 | — | — | US | disclosed |
| US-12111310-B2 | Pretreatment agent in non-agglutination assays | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-10-08 | — | — | US | disclosed |
| CN-112004524-B | Drug delivery system | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2024-09-10 | — | — | CN | disclosed |
| US-20240159781-A1 | SANDWICH ASSAY FOR SMALL MOLECULES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-11913965-B2 | Sandwich assay for small molecules | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-02-27 | — | — | US | disclosed |
| CN-116457657-A | Determination method of relative fu ratio based on dynamic analysis | 中外制药株式会社 | 2023-07-18 | — | — | CN | disclosed |
| US-11592439-B2 | Pretreatment agent in non-agglutination assays | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2023-02-28 | — | — | US | disclosed |
| US-20230041197-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNOMODULATOR | GLAS USA LLC | 2023-02-09 | — | — | US | disclosed |
| EP-4036572-A1 | METHODS FOR DETECTION OF IMMUNOSUPPRESSANT DRUGS | Siemens Healthcare Diagnostics Inc. (US) | 2022-08-03 | — | — | EP | disclosed |
| US-11377483-B2 | Sandwich assay design for small molecules | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-07-05 | — | — | US | disclosed |
| EP-2176658-B1 | METHODS FOR DETECTION OF IMMUNOSUPPRESSANT DRUGS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2022-06-01 | — | — | EP | disclosed |
| US-20160052972-A1 | NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION | S&T GLOBAL INC. | 2016-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160052972-A1 | NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION | HAVCR2, TSLP, ICOS | ABCB1 198/4885FPR1 1029/4885PPIA 710/4885 |
| US-11377483-B2 | Sandwich assay design for small molecules | SHBG, SERPINA6, SPR | ABCB1 4290/4885FPR1 4318/4885PPIA 3820/4885 |
| US-20230041197-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNOMODULATOR | FABP2, IL2, TSLP | ABCB1 2564/4885FPR1 1026/4885PPIA 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.